Li Ke, Sacks Steven H, Sheerin Neil S
King's College London, Department of Nephrology and Transplantation, Guy's Hospital London, London SE1 9RT, UK.
Mol Immunol. 2008 Feb;45(4):954-62. doi: 10.1016/j.molimm.2007.07.037. Epub 2007 Sep 17.
Urinary tract infection due to uropathogenic Escherichia coli is a common clinical problem. The innate immune system and the uroepithelium are critical in defence against infection. The complement system is both part of the innate immune system and influences the interaction between epithelium and pathogen. We have therefore investigated the mechanism by which uropathogenic E. coli activate complement and the potential for this to occur during clinical infection. The classical pathway is responsible for bacterial opsonisation when complement proteins are present at low concentrations. At higher concentrations the alternative pathway predominates but still requires the classical pathway for its initiation. In contrast the mannose binding lectin pathway is not involved. Early classical pathway components are present in the urine during infection and actively contribute to bacterial opsonisation. The classical pathway could be initiated by anti-E. coli antibodies of IgG or IgM subclasses that are present in urine during infection. Additionally immunoglobulin-independent mechanisms, such as direct C1q binding to bacteria, may be involved. In conclusion, uropathogenic E. coli are readily opsonised by complement in a classical pathway dependent manner. This can occur within the urinary tract during the development of clinical infection.
由尿路致病性大肠杆菌引起的尿路感染是一个常见的临床问题。天然免疫系统和尿路上皮在抵御感染方面至关重要。补体系统既是天然免疫系统的一部分,又影响上皮细胞与病原体之间的相互作用。因此,我们研究了尿路致病性大肠杆菌激活补体的机制以及这种情况在临床感染期间发生的可能性。当补体蛋白浓度较低时,经典途径负责细菌调理作用。在较高浓度时,替代途径占主导,但仍需要经典途径来启动。相比之下,甘露糖结合凝集素途径不参与其中。感染期间尿液中存在早期经典途径成分,并积极参与细菌调理作用。经典途径可能由感染期间尿液中存在的IgG或IgM亚类的抗大肠杆菌抗体启动。此外,可能涉及免疫球蛋白非依赖性机制,如直接C1q与细菌结合。总之,尿路致病性大肠杆菌很容易以经典途径依赖的方式被补体调理。这可能在临床感染发展过程中发生在尿路内。